[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100528563":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":28,"responsibleParty":46,"collaborators":18,"id":48,"slug":18,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":18,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":18,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":18,"overallStatus":31,"whyStopped":18,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Peripheral Nerve Stimulation","EXPERIMENTAL","Participants will be asked to have PNS leads inserted via a needle, which will provide a mild, stimulating electrical current to the effected nerves 24 hours a day for up to 60 days. Participants will have study visits during and after this time.",[13],"Other: Peripheral Nerve Stimulation",[15],{"type":6,"name":9,"description":16,"armGroupLabels":17,"otherNames":18},"The leads are inserted through a needle. If needed, the study team may give participants anesthetic (for example, as a cream\u002Fgel on your skin and\u002For as an injection) to numb the area where the leads will be injected.",[9],null,[20],{"name":21,"affiliation":5,"role":22},"Saba Javed, MD","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":18,"email":27},"CONTACT","(713) 792-9530","sjaved@mdanderson.org",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"MD Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States",{"type":37,"coordinates":38},"Point",[39,40],-95.36327,29.76328,{"lat":40,"lon":39},[43,45],{"name":21,"role":25,"phone":44,"phoneExt":18,"email":27},"713-792-9530",{"name":21,"role":22,"phone":18,"phoneExt":18,"email":18},{"type":47,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100528563",false,"NCT06162403","Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study","Inclusion Criteria:\n\n* Participants diagnosed with chronic (≥90 days duration) CIPN (due to either vinca alkaloids, taxanes, bortezomib, thalidomide, platinum-based compounds or ionizing irradiation) of the lower extremity, seen at Pain Management Center at MD Anderson Cancer Center\n* Participants reports baseline pain ≥ 4 (0-10 scale, NRS)\n* Participants between ages 18-85 years old\n* Participants who have completed chemotherapy within the previous year at the time of enrollment\n\nExclusion Criteria:\n\n* Participants with cognitive dysfunction\n* Participants with recent history (\\\u003C6 months) of drug or alcohol abuse\n* Participants with open skin lesion or undergoing antibiotic therapy for local for systemic infection\n* Participants with allergies to local anesthesia, steroids, or adhesives\n* Participants with conditions that conflict with the SPRINT PNS System Indications for Use, including Contraindications and Warnings.","ALL","18 Years","85 Years",{"count":57,"type":58},10,"ESTIMATED","INTERVENTIONAL",[61],"NA","To learn if peripheral nerve stimulation (PNS) can help to improve pain in participants with CIPN.",[9,64],"Chemotherapy-induced Peripheral Neuropathy","2026-02-17",{"date":67,"type":68},"2026-02-19","ACTUAL",{"date":70,"type":68},"2024-02-22",{"date":72,"type":58},"2027-12-31",{"name":5,"class":6},1]